Matthew Angel

Director & CEO and President

Director & CEO and President at Tempest Therapeutics, Inc., filing insider transactions on 2026-03-24.

Total Purchases

$1.0M

2 transactions

Total Sales

—

0 transactions

Companies Traded

1

2 total filings

Active Since

2026-03-24

Last: 2026-03-24

Companies

Tempest Therapeutics, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-03-24	TPST	Purchase	231.5K	$2.16	$500K	231.5K	SEC ↗
2026-03-24	TPST	Purchase	231.5K	$2.16	$500K	231.5K	SEC ↗

Matthew Angel (Tempest Therapeutics, Inc.) Insider Trades | Tormere